| Financial Year |
March 31 2023 |
| Monetary Funds |
1,168,765,626.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,249,513.35 |
| Accounts Receivable |
4,589,664,685.76 |
| Advances to Suppliers |
250,734,654.89 |
| Other Receivables |
330,613,237.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
52,526,297.25 |
| Inventories |
477,312,048.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
639,074,442.06 |
| Total Current Assets |
7,457,414,208.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,932,314,286.07 |
| Investment Properties |
54,045,869.10 |
| Fixed Assetes |
23,861,045,884.29 |
| Under-construction Projects |
725,490,462.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,351,401,080.98 |
| R&D expenses |
-- |
| Goodwill |
75,399,974.47 |
| Long-Term Deferred and Prepaid Expenses |
694,090,638.03 |
| Deferred Income Tax Assets |
124,556,005.58 |
| Other Non-Current Assets |
124,353,893.40 |
| Sub-Total of Non-Current Assets |
33,057,581,356.19 |
| Total Assets |
40,514,995,564.80 |
| Short-Term Loans |
1,732,469,259.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,325,718,792.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
216,760,899.06 |
| Taxes Payable |
328,707,696.82 |
| Interest Payable |
-- |
| Dividend Payable |
92,891,526.59 |
| Other payables |
1,161,864,464.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,905,032,982.91 |
| Other Current Liabilities |
365,390,335.44 |
| Sub-Total of Current Liabilities |
8,042,260,341.21 |
| Long-term Loans |
10,310,956,487.17 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,087,190.24 |
| Deferred Income Tax Liabilities |
83,183,705.67 |
| Other Non-Current Liabilities |
18,240,681.13 |
| Sub-Total of Non-Current Liabilities |
10,564,278,776.83 |
| Total Liabilities |
18,606,539,118.04 |
| Paid-In Capital(Or Share Stock) |
6,526,887,811.00 |
| Capital Surplus |
1,572,302,177.08 |
| Surplus Reserve |
1,866,065,635.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,700,573,976.51 |
| Minority Stockholder's Interest |
3,427,337,436.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,481,119,010.51 |
| Owner's Equity（Stockholder's Equity） |
21,908,456,446.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,514,995,564.80 |
